Get started

Fundamental-analysis

Expecting blast again in upside - ZEEL (Channel BO) Recent days in media stocks blasting up-side frequently. Its more of intuitional buying because every rise on the price equally increasing volume also. This the sector under perform comparing to other sector, expecting to out perform. Zeel is leader of this sector, last year decreasing it's debt gradually. QoQ result improved. Technical & fundamental is favoring to give up move quickly. Note: It's educational purpose not for recommendation.
NSE:ZEELLong
by prabu_view
opportunity for long term investment in INDUS TOWERSIndus Towers Limited is formed by the merger of Bharti Infratel Limited and Indus Towers. This combined strength makes Indus one of the largest telecom tower companies in the world. Indus Towers Limited has over 183,462 towers and a nationwide presence covering all 22 telecom circles. Indus’ leading customers are Bharti Airtel (together with Bharti Hexacom), Vodafone Idea Limited and Reliance Jio Infocomm Limited, which are the leading wireless telecommunications service providers in India by revenue. FUNDAMENTAL ANALYSIS- 1. company is profitable and upgrading in their revenue year by year. 2. increase in revenue ,EBITA , PBT , EPS and can see a increase in free cash flow. 3. great dividend yield (6.84% ) 3. as we can see how telecom and data sector is growing, this stock is going to grow with that sector. company working model is base of this sector plus tie ups are with sector leaders. negative points about company- 1.their is pledging in promotors holdings. 2.dept to equity increases this year ( now -0.44 ) TECHNICAL ANALYSIS- 1. on monthly chart downtrend is broken by strong bullish candle with volume. 2. on weekly time frame after breakout slightly retested and pullback is observed. 3. on daily time frame, stock is creating volatility for couple of days going to break on either side ( down or up) 4. recommended to accumulate stock as chances are more to break upside once it closes around 298 to 300 range on daily time frame stock is going to show upside move. this study is for education purpose only.
NSE:INDUSTOWERLong
by ameyagawade9
TATVA ready for some good movesTatva Chintan Pharma Chem Limited is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates, and other Speciality chemicals. WHY IT MIGHT GIVE A GOOD MOVE NOW: Tatva's IPO's QIB was oversubscribed by 185.23 times. Meaning, institutions that planned to buy 50,000 shares got only 269 shares in the allotment. After the IPO Listing, the price dropped by 20.62% obviously due to listing gains enjoyed by retailers. For 11 weeks the share price formed a base and gave good time for big hands to accumulate. On the 12th week the price broke out of the IPO Listing price with huge volumes (the day before & the day after also) Out of 5.29 lac shares traded that day, 3.23 lac were traded in the last 30 minutes. This confirms my hypothesis of the Entry of big hands during the breakout. The price then tested 2 times the IPO listing high and took good support on it. Tatva's Q2 results also dropped on 22nd October (before 3 big volume days) and the Q2 numbers beat both QoQ & YoY numbers which might be the trigger. Key Points of the Company Leading Chemical Manufacturer Tatva Chintan operates in the space of niche specialty chemicals and is a globally recognized specialty chemical player with several market-leading products in its portfolio. The co. is the largest and only commercial manufacturer of structure-directing agents for zeolites in India (second globally) and caters to a wide range of industries across the globe. Product portfolio: The company has manufactured over 154 products which can be divided into the following four broad categories Structure Directing Agents (40% of the revenue) The Company’s SDAs are quarternary salts which are chemicals used in the Zeolite application. Zeolites have varied applications it is promoted with transition metals such as copper and iron to be active for selective catalytic reduction. Phase Transfer Catalysts (27% of the revenue) PTC’s are widely used in green chemistry applications and are used for a variety of industrial processes. Phase transfer catalysts are a type of catalyst that allows a reactant to be migrated from one phase to another. Electrolyte salts for supercapacitor batteries (1% of the revenue) The Company’s electrolyte salts are used in the manufacture of supercapacitor batteries, which are used in automobile batteries and other batteries. The Company is the largest producer of electrolyte salts for supercapacitor batteries in India. Pharmaceutical, agrochemicals, and other specialty chemicals (30% of the revenue) The products manufactured by the company under this category are used in the manufacture of various pharmaceutical and agrochemical products as intermediates, disinfectants, and catalysts, and solvents. In addition, the company also manufacture specialty chemicals under this category that are used in dyes and pigments, personal care ingredients, flavor, and fragrance sectors The Company has 47 products under their SDA product portfolio, 48 products under the PTC product portfolio, 6 products under the electrolyte salts for supercapacitor batteries portfolio, and 53 products under their PASC portfolio. Manufacturing facilities The Company operates through two manufacturing facilities situated at Ankleshwar and Dahej in Gujarat, both of which are strategically located very close to the Hazira port. These manufacturing facilities have an annual installed reactor capacity of 280 KL and 17 Assembly Lines. Exports-driven The company derives a majority of its revenue through exports (71% of the revenue) with Germany, the U.S., and China together accounting for 54.20%. Its top 10 customers constitute 60% of revenue. Clientele List The customers of the Company include Merck, Bayer AG, Asian Paints Ltd., Ipox Chemicals KFT, Laurus Labs Ltd, Tosoh Asia Pte. Ltd., SRF Limited, Navin Fluorine International Limited, Oriental Aromatics Ltd., Atul Limited and many others. R&D Infrastructure The company has a dedicated R&D facility, recognized by the DISR at Vadodara, Gujarat. The company has developed 53 products in the last three years which contributed 6.5 Crs revenue for the company. Successful listing The company got listed on the secondary exchanges on July 29 2021 with a 114% premium from its issue price. The 500 Crs issue got subscribed 180 times and became the most over subscriber IPO of 2021. The issue constituted of 275 Crs Offer for sale by the promoters and a fresh issue of 225 Crs. Growth Strategies: Expanding the Manufacturing Capabilities: The Company has consistently grown its manufacturing and production capabilities. The Company’s aggregate manufacturing capacity has increased at a CAGR of 20.59% from an aggregate reactor capacity of 82 KL and zero Assembly Lines in FY2010 to 280 KL Reactor Capacity and 17 Assembly Lines as of FY21. The company will expand its Dahej Manufacturing facility and upgrade its R&D Infra with a CAPEx to the tune of 170 Crs. Expand the existing product portfolio The Company plans to continue to increase offerings in their current business segments as well as diversify into new products by tapping into segments which in the view of the company’s management have attractive growth prospects.
NSE:TATVALong
by AmanSaraf
5
Great long term investment in insurance sector fundamental analysis- 1. shareholding 73.42% promotor holdings ( unpledged ) 17.17% FII investors 4.14% DII investors almost 95% holdings is in strong hands. 2.performace 56.62% 1 year performance (better than peers) net sales are better than peers.( Rs.2,755 ) financials are getting quite stronger. *reason to invest in insurance sector- Having a look at the current market scenario, we can find that LIC has taken over a major part in the overall Insurance Industry in India. However, given the rate of growth in the other Non-life insurance sectors, it is estimated that they are sure to compete with Life insurance companies in the years to come. New insurance companies rising up in the market will definitely experience a vibrant growth and expansion both in the Life as well as General insurance sectors. The general insurance industry is expected to increase by 7-9% in terms of gross direct premium income in FY22, backed by healthy growth from the health and motor segments. technical analysis - on daily frame it looks like bullish flag pattern. short downtrend was recently broken and retested also with a great heavy volume. time to accumulate the stock for long term. this study is for education purpose only.
NSE:ICICIPRULI
by ameyagawade9
2
NMDC_Pick for the Long TermPick for the Long Term! NMDC is fundamentally very strong counter with very low PE level of 4.68. On technical chart, best levels for accumulation would be from CMP to 132. PE 4.68 Profit Margin 45% Promotor Holding 61% Company is almost debt free Stock is providing a good dividend yield of 5.45% Company is expected to give good quarter Company has delivered good profit growth of 19.78% CAGR over last 5 years Company has been maintaining a healthy dividend payout of 39.39% The best thing is that the stock has corrected and consolidated for quite a long time now. Buy and accumulate till 132 level.
NSE:NMDCLong
by Amey_Kadam
Sree Rayalaseema Hi-Strength Hypo Ltd Buy for Mid/ Long TermSree Rayalaseema Hi-Strength Hypo Ltd may be considered a buy for Long term. Please read every point before taking entry - Enter only and only if you feel confident, and if you feel what is written here is acceptable. Factors for entry: 1. Fundamentally strong (Please go through the fundamentals of the company before messaging me, its easy and direct) 2. The Company is engaged in manufacturing and sale of industrial chemicals and generation and distribution of power - Chemical will be the next segment I will be concentrating on. 3. Technically - weekly trendline broken, strong bullish candles 4. Upper support levels are broken. However, I won't recommend to buy completely now. I will personally start building my portfolio slowly (I am expecting it to retest the bottom trendline again, if not then I am satisfied with the present entry). Initial marked SL i.e below 270, is if people are taking an entry in CMP (What I suggest is better to build the portfolio, slowly adding more if its coming down). The dark blue line may be followed if daily candle closing strongly above the resistance zone. I am expecting a retest - so high probability of the dotted line to follow is there. A safe SL is below 220 (This would be my SL) TGT: 400/450/500 ++ Disclaimer: These are just my views, I am only SHARING my views - kindly do NOT trade blindly with these levels, please do your own research before entering/ or as per advice from your own financial adviser. This is for a mid to long term investment only, its not a positional or an intraday trade PS: Since I am presently sailing- I wont be able to do any intraday trade, and this is the reason why I am not posting any intraday/ positional trades. As and when a good stock appears for mid/ long term investment, I will try to post.
NSE:SRHHYPOLTDLong
by theTradingSailor
Astrazenca Pharma India Ltd Share Analysis with Technical TargetCHART OF AstraZenca Pharma Ltd 1. Today we'll discuss another stock which is AstraZenca Pharma Ltd 2. Today Date is 19-09-2021 3. Currently stock is trading at 3139.90 which is shown in candle chart. 4. As per my learning there is Technical Target 3950 which is shown in image above, which is approximately 25% gain. 5. How much time it takes to reach target, according to my analysis, it takes maximum 4 to 5 months. 6. Stock is trading in good support which is clearly shown in above chart and we can hold till resistance. IMPORTANT RULES 07. Only invest 3 % of your capital in one stock, Please don't ignore this rule because we are investing our hard-earn money here so risk management is best part of trading. 08. We never sell stock in loss. 09. We are investing in equity share. 10. Patience is the key in equity, sometime great company went down that is the opportunity to buy these companies because we know they will come back very quickly. Disclaimer:- I'll post here stocks analysis for educational purpose where you can learn. This blog is totally educational purpose, not a recommendation of stocks buy or sell.
NSE:ASTRAZEN
by mantusharma13
3
How To Use Financial Ratios To Make Better DecisionsFinancial Ratios help you evaluate a company. Most financial ratios will show you how much money you're paying for a specific piece of the business. Let us give a few examples: Price-to-Sales Ratio = Market Cap / Sales The Price-To-Sales ratio or PS ratio tells you how expensive a company is relative to its total sales. The formula is calculated in two different ways: divide the company's market capitalization by its revenue or divide the current stock price by revenue-per-share. Because this ratio is being calculated with live price information, you can also watch it in real-time on the chart as we've shown in this example above. If a company has a market cap of $10 billion and revenue of $1 billion, well that, that implies a PS ratio of 10. You're paying $10 for every $1 in sales. You can do ratios like this for all aspects of the company. For example, PE ratio or Price-To-Earnings ratio measures the Market Cap / Earnings . This tells you how much you're paying for every dollar of earnings . Keep in mind that Financial Ratios are not perfect. They are also not a buy or sell recommendation. Instead they are shortcuts, ways to quickly evaluate a company, compare its underlying fundamentals, and study that company relative to other companies. You also must remember that financial metrics can change quickly with a single earnings report. A company's future expectations are also just as important. A company like Apple might have a high PE ratio, but if they're building and growing revenue into the future, their PR ratio could come down over time. Remember, Financial Ratios and Financial metrics in general paint a picture of the underlying business and its earnings potential. Here are some other resources to get you started: 1. Read more about Financials on TradingView in our Help Center. 2. You can also code your own strategy or indicator using this financial information . 3. We've also created a library in our Help Center so you can learn more about every Financial metric . Here are some other financial ratios that you may find interesting and how they're calculated: PE Ratio = Market Cap / Earnings PB Ratio = Market Cap / Book PEG Ratio = PE / Earnings Growth Quick Ratio = (Cash + Cash Equivalents + Current Receivables + Short Term Investments) / Current Liabilities Dividend Yield = Dividends Per Share / Price EV Multiple = Enterprise Value / EBITDA To access all of the Financial Ratios available to you, click the Financials button at the top of your chart. From here, you can select many different Financial metrics and study markets at a deeper level. More importantly, you can combine the study of Technical and Fundamental analysis at the same time. Meaning you can evaluate the fundamental side of the business including its earnings and valuation while ALSO studying price action and planning a trade. Please feel free to share your feedback and comments below! Thank you for reading.
Editors' picks
NASDAQ:AAPLEducation
by TradingView
8